Type 1 Diabetes

Latest News

Nephropathy Progression in Type 1 Diabetes Linked to Depression

By

Jody A. Charnow

Whether successful treatment of depression reduces the risk for progression needs to be determined.

Sotagliflozin Reduces Risk for Adverse CV Events in Diabetic Kidney Disease

By

Natasha Persaud

Sotagliflozin might help patients with diabetes and chronic kidney disease who are hospitalized with heart failure avoid a readmission, study results suggest.

Group-Based Lifestyle Intervention Reduces T2DM Progression

A low-cost, group-delivered lifestyle intervention is associated with a significantly lower risk for progression to type 2 diabetes among high-risk individuals.

Younger Age, Female Sex, and HbA1c Linked to C-Peptide Decline in Pediatric T1D

By

Corinna Panlilio Sison, MD

Investigators sought to determine whether younger age at diagnosis, female sex, and higher weight z score and HbA1c are risk factors for C-peptide decline after new onset of pediatric type 1 diabetes.

Real-Time CGM Improves Hypoglycemia-Related Glucose Control

By

Amit Akirov, MD

The study goal was to determine whether real-time continuous glucose monitoring up to 24 months is beneficial, particularly in persons living with impaired awareness of hypoglycemia.

Teplizumab BLA for Tyoe 1 Diabetes Prevention Submitted

By

Brian Park, PharmD

The BLA is supported by data from a phase 2 trial that evaluated whether teplizumab could prevent or delay the onset of T1D in at-risk individuals.

Finerenone Slows CKD Progression in Diabetic Kidney Disease

By

Jody A. Charnow

Finerenone vs placebo added to standard therapy was associated with a significant 18% reduction in the risk for major adverse kidney events in patients with both chronic kidney disease and type 2 diabetes mellitus.

FRAX Without BMD Predicts Risk for Fracture in Adult T1D

By

Rose Reeb

Clinical use of FRAX without bone mineral density can be used to identify adults with type 1 diabetes who are at elevated risk for major osteoporotic fracture.

COVID-19 Pandemic Linked to Altered T1D Diabetes Presentation in Children

By

Brandon May

The effects of the COVID-19 pandemic on the diagnosis and presentation of pediatric type 1 diabetes.

Diabetic Ketoacidosis Rates in Children With New T1D Diagnosis During COVID-19

By

Brandon May

Children who received a new diagnosis of type 1 diabetes during the COVID-19 pandemic are presenting with higher rates of diabetic ketoacidosis than in the previous 2 years.

Vitamin D Deficiency Linked to Painful Diabetic Neuropathy

By

Amit Akirov, MD

Vitamin D supplements may significantly improve neuropathic symptoms, including pain and quality of life.

Hip, Nonvertebral Fracture Risk Higher in Patients With Diabetes

Individuals with diabetes have an increased risk for hip and nonvertebral fractures.

Ready-to-Use Glucagon Pen Now Available for Severe Hypoglycemia

By

Brian Park, PharmD

Xeris Pharmaceuticals announced the launch of Gvoke HypoPen™ (glucagon) for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 2 years and older.

Recommendations for Management of Diabetic Ketoacidosis in COVID-19

By

Amit Akirov, MD

A clinical perspective article details the recommended approach to manage diabetic ketoacidosis in patients with diabetes during the COVID-19 pandemic.

Benefits of Continuous Glucose Monitoring Systems in the Hospital Setting

By

Amit Akirov, MD

Continuous glucose monitoring is a safe and useful method to measure blood glucose levels in the hospital, especially during the COVID-19 pandemic.

Associations Between Pemphigus and Type 1 Diabetes, Type 2 Diabetes

By

Rachael Beairsto

The association of pemphigus with type 1 (T1DM) and type 2 diabetes mellitus (T2DM) is assessed.

Hyperglycemia Common in Patients With T1D and COVID-19

Presentation patterns are similar in patients with type 1 diabetes admitted with confirmed or suspected COVID-19.

Acute Hyperglycemia Impairs Spatial Working Memory in Adolescents With T1D

By

Rose Reeb

Acute hyperglycemia affects brain metabolite concentration and performance on spatial working memory tasks in adolescents with type 1 diabetes.

New Rapid-Acting Insulin Lispro Approved by FDA

By

Brian Park, PharmD

The FDA has approved Lyumjev™ (insulin lispro-aabc injection; Lilly) to improve glycemic control in adults with type 1 and type 2 diabetes.

FDA Approves Long-Acting Insulin Glargine Injection for T1D, T2D

By

Brian Park, PharmD

The FDA has approved Semglee™ (insulin glargine injection; Mylan and Biocon) to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.